Pfizer recalls 1.5g vancomycin injections with glass particles that could cause serious injury during injection. Affected lots from 33045BA to 1SEP2023. Stop using immediately.
“Pfizer Vancomycin Hydrochloride Injections Recall: Glass Particulate Matter Hazard.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/34151-pfizer-vancomycin-hydrochloride-injections-recall-glass-particulate-matter-hazard. Based on FDA recall #D-0184-2023 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0184-2023%22&limit=1).
The FDA announced on Dec. 22, 2022, that Pfizer Inc. is recalling Vancomycin Hydrochloride for Injection due to the presence of glass particulate matter. This voluntary Class I recall affects 89,700 vials distributed nationwide.
The recall was initiated because glass particulate matter was detected in the injectable solution. The FDA classified this as a Class I hazard, indicating a reasonable probability that the product will cause serious adverse health consequences or death.
Context
GovInfoNow's records show Pfizer Inc. has issued 71 other recalls since Nov. 26, 2012. Recent Pfizer recalls include a Sodium Bicarbonate Injection recall on Aug. 4, 2025, for lack of sterility assurance, and a Bicillin L-A Injectable Suspension recall on July 10, 2025, due to particulate risk. Other recent recalls of similar products include Sun Pharmaceutical DOXOrubin Liposome Injection Recall (May 12, 2026) and American Regent Papaverine HCl Injection Recall (July 24, 2026).
How to tell if you have this one
Check for vials labeled 'Vancomycin Hydrochloride for Injection, USP, 1.5 g/vial' with NDC vial code 0409-3515-11 and carton code 0409-3515-01. The lot number 33045BA was distributed until expiration date 1SEP2023.
Brand
Pfizer
Category
Drug
Based on the official FDA remedy
What to do — step by step
Stop Using Immediately
Discard all recalled vials and cartons immediately to prevent potential injury.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “USA nationwide and Puerto Rico” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 20 months after the firm started it.
1Firm started the recall
2FDA classified it Class I
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0184-2023 (December 22, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0184-2023 to see it in context.
Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.